ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 735037 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 735037; 2) Community: the network communities that were significantly associated with the response to NSC 735037; 3) Molecule: the relationships between components within communities and NSC 735037; 4) MDR: the compounds that were significantly associated with the NSC 735037.

NSC Compound Enrichment Correlation
NSC 53327 Null 0.0454469012959173 0.30061022
NSC 58906 9H-Purine, 6-[(o-chlorobenzyl)thio]-9-(2-chloroethyl)- (8CI) 0.0454469012959173 0.49379588
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.0454469012959173 0.36922535
NSC 603831 Acteoside 0.0454469012959173 0.43859678
NSC 606498 Camptothecin Derivative 0.0454469012959173 0.72274586
NSC 609699 Topotecan hydrochloride 0.0454469012959173 0.82871189
NSC 620277 4-N,N-bis-2'-cyanoethylaminobenzylidene-4-fluoro aniline 0.0454469012959173 0.10088741
NSC 623176 Null 0.0454469012959173 0.33632298
NSC 629974 7H-1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine, 3-(4-chlorophenyl)-6-(5-nitro-2-furanyl)- (9CI) 0.0454469012959173 0.17823247
NSC 638788 2-N-Methyl-6-oxaellipticinium acetate 0.0454469012959173 0.08614697
Total:91  Current:78    [First] [Prev] [Next] [Last]